Annual Securities Report — FY2025
What SHOEI YAKUHIN CO.,LTD. reported for the period from 2025-04-01 to 2026-03-31. Filed by 昭栄薬品株式会社
Filed 2026-06-24View the original on EDINET
How much it says
55Typical
What moved here
19named for the first time
Its own wording
54terms
Which filing this is
37/ 37newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
昭栄薬品 reports its consolidated results and financial position for the fiscal year ended March 2026 (1 April 2025 to 31 March 2026), along with its principal businesses and risks, corporate governance and other matters. The report focuses on describing results through the fiscal year-end and standard disclosure content, rather than on the occurrence of any specific major event.
Komori's summary of this document, not the document's own words.55Typical
How much this filing saysA weighted roll-up of 11 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 37 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
76
Very detailed
38
Thin
33
Thin
100
Very detailed
100
Very detailed
68
Detailed
27
Almost nothing
31
Thin
7
Almost nothing
55
Typical
73
Detailed
R&D spendNot disclosedThis document does not carry the figure.
Cash left over4億円Cash from the business, less what went into equipment.
Spent on equipment6百万円Plants, machines — things meant to last.
Employees60Headcount at the end of this period.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.